NCT05422677View on ClinicalTrials.gov

An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

CompletedOBSERVATIONAL
Enrollment

4,698

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

August 24, 2021

Study Completion Date

August 24, 2021

Conditions
BPHBenign Prostatic Hyperplasia
Interventions
DRUG

Hanmi Tams® Capsule

Hanmi Tams®, Once daily administered per the locally approved product information

Trial Locations (1)

05545

Hanmi Pharmaceutical Company Limited, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY